Cargando…

Uncontrolled hyperlipidemia in Chinese patients who experienced acute coronary syndrome: an observational study

OBJECTIVE: Despite current standard of care, the overall lipid goal attainment rate for hyperlipidemia patients, especially those who have experienced acute coronary syndrome (ACS), is suboptimal, which predisposes them to a higher residual risk of atherothrombotic events. This study aimed to descri...

Descripción completa

Detalles Bibliográficos
Autores principales:	Jiang, Jie, Zhou, Yu-Jie, Li, Jian-Jun, Ge, Jun-Bo, Feng, Ying-Qing, Huo, Yong
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Dove Medical Press 2018
Materias:	Original Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6247970/ https://www.ncbi.nlm.nih.gov/pubmed/30532548 http://dx.doi.org/10.2147/TCRM.S178318

Ejemplares similares

Hyperlipidemia does not influence clinical outcome in arthroscopic treatment of femoroacetabular impingement syndrome
por: Yang, Fan, et al.
Publicado: (2022)

Polygenic Hyperlipidemias and Coronary Artery Disease Risk
por: Ripatti, Pietari, et al.
Publicado: (2020)

Plasma levels of lipometabolism-related miR-122 and miR-370 are increased in patients with hyperlipidemia and associated with coronary artery disease
por: Gao, Wei, et al.
Publicado: (2012)

Efficacy of Cilostazol on Uncontrolled Coronary Vasospastic Angina: A Pilot Study
por: Yoo, Sang-Yong, et al.
Publicado: (2013)

Coronary Artery Disease Risk and Lipidomic Profiles Are Similar in Hyperlipidemias With Family History and Population‐Ascertained Hyperlipidemias
por: Rämö, Joel T., et al.
Publicado: (2019)

Long-term follow-up of antithrombotic management patterns in patients with acute coronary syndrome in China
por: Han, Xiao-Ning, et al.
Publicado: (2020)

A cognitive behavioural intervention for low self‐esteem in young people who have experienced stigma, prejudice, or discrimination: An uncontrolled acceptability and feasibility study
por: Langford, Katie, et al.
Publicado: (2021)

Untargeted lipidomics and metagenomics reveal the mechanism of aspirin eugenol ester relieving hyperlipidemia in ApoE−/− mice
por: Lu, Xiao-Rong, et al.
Publicado: (2022)

Risk Prediction Model for Uncontrolled Hypertension in Chinese Community
por: Gao, Zhiping, et al.
Publicado: (2022)

Prevalence and associated factors of uncontrolled hyperlipidemia among Thai patients with diabetes and clinical atherosclerotic cardiovascular diseases: a cross-sectional study
por: Lertwanichwattana, Teeraboon, et al.
Publicado: (2021)

Dramatic escalation in metabolic syndrome and cardiovascular risk in a Chinese population experiencing rapid economic development
por: Lao, Xiang Qian, et al.
Publicado: (2014)

Phytosterols Alleviate Hyperlipidemia by Regulating Gut Microbiota and Cholesterol Metabolism in Mice
por: Lv, Wei-Jie, et al.
Publicado: (2023)

How Is the Sexual Function of Premenopausal Chinese Women Without Hyperlipidemia?
por: Xiang, Yali, et al.
Publicado: (2019)

Regulation effect of Aspirin Eugenol Ester on blood lipids in Wistar rats with hyperlipidemia
por: Karam, Isam, et al.
Publicado: (2015)

Social support and cognitive function in Chinese older adults who experienced depressive symptoms: is there an age difference?
por: Jing, Yurong, et al.
Publicado: (2023)

Monogenic hyperlipidemias
por: Krasi, Geraldo, et al.
Publicado: (2019)

Hyperlipidemias and Obesity
por: Thiriet, Marc
Publicado: (2019)

Genetic predisposition to type 2 diabetes is associated with severity of coronary artery disease in patients with acute coronary syndromes
por: Zheng, Qiwen, et al.
Publicado: (2019)

Outcomes of in-hospital treatment of cardiac patients who survived cardiac arrest and experienced coronary angiography
por: Barauskas, Mindaugas, et al.
Publicado: (2018)

Uncontrolled Hypertension Increases with Age in an Older Community-Dwelling Chinese Population in Shanghai
por: Peng, Sheng, et al.
Publicado: (2017)

Statin and metformin therapy in prostate cancer patients with hyperlipidemia who underwent radiotherapy: a population-based cohort study
por: Li, Ke, et al.
Publicado: (2019)

The Mechanism of Dendrobium officinale as a Treatment for Hyperlipidemia Based on Network Pharmacology and Experimental Validation
por: Li, Lin-Zi, et al.
Publicado: (2022)

Association between polymorphisms in the APOB gene and hyperlipidemia in the Chinese Yugur population
por: Gu, Q-L., et al.
Publicado: (2017)

Gut Microbiota-Mediated Personalized Treatment of Hyperlipidemia Using Berberine
por: Wang, Yan, et al.
Publicado: (2017)

Eye movement verification and evaluation of initial sandplay picture system for internet addiction symptoms in Chinese adolescents
por: Ge, Ying, et al.
Publicado: (2023)

Mechanism of rhubarb in the treatment of hyperlipidemia: A recent review
por: Wu, Lijiao, et al.
Publicado: (2023)

Effect of glycemic state on postprandial hyperlipidemia and hyperinsulinemia in patients with coronary artery disease
por: Nakamura, Akihiro, et al.
Publicado: (2015)

Thermostable ionizable lipid-like nanoparticle (iLAND) for RNAi treatment of hyperlipidemia
por: Hu, Bo, et al.
Publicado: (2022)

Exome-Wide Association Study Reveals Several Susceptibility Genes and Pathways Associated With Acute Coronary Syndromes in Han Chinese
por: Zheng, Qiwen, et al.
Publicado: (2020)

CETP gene polymorphisms and risk of coronary atherosclerosis in a Chinese population
por: Wang, Jun, et al.
Publicado: (2013)

Hypolipidemic effect of XH601 on hamsters of Hyperlipidemia and its potential mechanism
por: Zhao, Meng-Jie, et al.
Publicado: (2017)

Klinefelter syndrome in an adolescent with severe obesity, insulin resistance, and hyperlipidemia, successfully treated with testosterone replacement therapy
por: Fukuhara, Shota, et al.
Publicado: (2021)

Aspirin eugenol ester regulates cecal contents metabolomic profile and microbiota in an animal model of hyperlipidemia
por: Ma, Ning, et al.
Publicado: (2018)

Hyperlipidemia and lipedematous scalp
por: Bukhari, Iqbal, et al.
Publicado: (2004)

Chinese expert consensus on the non-invasive imaging examination pathways of stable coronary artery disease
por: Chen, Yun-Dai, et al.
Publicado: (2018)

Developing a Core Outcome Set for Clinical Trials of Chinese Medicine for Hyperlipidemia
por: Li, Geng, et al.
Publicado: (2022)

Primary hyperlipidemias : an atlas of investigation and diagnosis /
por: Davignon, J.
Publicado: (2009)

Incidence, Predictors, and Prognosis of Coronary Slow-Flow and No-Reflow Phenomenon in Patients with Chronic Total Occlusion Who Underwent Percutaneous Coronary Intervention
por: Wang, Yong, et al.
Publicado: (2020)

Bernard–Soulier syndrome (BSS) with uncontrollable menorrhagia
por: Bhadra, Debasmita, et al.
Publicado: (2020)

Atorvastatin reduces serum HMGB1 levels in patients with hyperlipidemia
por: JIN, DAOQUN, et al.
Publicado: (2012)

Cannot write session to /tmp/vufind_sessions/sess_u0tj2okuuqt13bmm8m5ae7oals